QUICK DIVE: Endometriosis: Hormonal Management Update (Manchester)

This meeting has been organised by CliniLink Ltd and is supported through sponsorship which covers the costs of exhibition stands. The sponsors Exeltis, Gedeon Richter and Theramex were not involved in the development of the agenda and have had no influence over the agenda, the speakers or the content of the meeting.

The symposium session only has been solely funded by AbbVie UK. AbbVie has selected the speaker and the content of the session. AbbVie products will be discussed


See Sponsors below

£0.00

Log in to Book

FACE TO FACE EVENT

THIS EVENT IS OPEN TO UK REGISTERED HEALTHCARE PROFESSIONALS ONLY

Location: Royal Nawaab Stockport Pyramid, Yew Street



Event Agenda

TimeTopicSpeaker
6:30 - 7:00Registration, Networking and Coffee
7:00 - 7:45Migraine: Impact, diagnosis and management approaches and Use of AQUIPTA® (atogepant) for the prophylactic management of episodic migraine This session ONLY has been solely funded by AbbVie UK. AbbVie has selected the speaker & content of the agenda, AbbVie products will be discussedDr Razaan Haneef – GPwER Migraine
7:45 - 8:45Established hormonal options in endometriosis
CHC, POP, LNG-IUS and GnRH agonists
Choosing therapy based on symptoms, fertility goals, side-effect profile, and long-term management
Newer and emerging treatments
Targeted progesterone therapies
Oral GnRH antagonist combination therapies
Ajay Swaminathan
8:45 - 9:00Q&A & Dinner

Why Should Healthcare Professionals Attend

Endometriosis: Hormonal Management Update

This CPD-accredited, face-to-face study day provides UK healthcare professionals with a practical, evidence-based update on the hormonal management of endometriosis.

Led by Mr Ajay Swaminathan, the session covers both established and emerging hormonal therapies, supporting clinicians to make confident, individualised treatment decisions based on symptoms, fertility goals, side-effect profiles, and long-term management needs.

Key Learning Outcomes

  • Review established hormonal options, including CHC, POP, LNG-IUS, and GnRH agonists

  • Learn how to tailor treatment to patient symptoms, reproductive plans, and tolerability

  • Understand newer and emerging therapies, including targeted progestogen therapies and oral GnRH antagonist combination therapies

  • Apply evidence-based guidance to real-world clinical practice

All attendees will receive a CPD certificate for full participation.



Meet the Speaker

Mr. Ajay Swaminathan

FRCOG MD
Ajay is a consultant gynaecologist and laparoscopic surgeon. Ajay joined the Mid Cheshire Hospitals NHS FT in 2012 after completing his training in the Mersey rotation. He is the endometriosis lead for the trust and also works at the Hewitt Fertility Centre at Knutsford – Liverpool Women’s Hospital.  Ajay maintains private practicing privileges at the Spire Regency Macclesfield, Circle Clinic Northwich and the BMI Beaumont. Ajay completed his laparoscopic training at the Kiel School of Gynaecological Endoscopy in Germany.  He is actively involved in medical education and training having served as a moderator for the Royal College on the Enhanced Revision Programme. He was the departmental lead for undergraduate medical education. He extends his educational outreach by lectures on gynaecological conditions to primary care physicians and allied health care professionals

Symposium

This session ONLY has been solely funded by AbbVie UK. AbbVie has selected the speaker & content of the agenda, AbbVie products will be discussed

Event Partners

This meeting has been organised by CliniLink Ltd and is supported through sponsorship which covers the costs of exhibition stands. The sponsors Exeltis, Gedeon Richter and Theramex were not involved in the development of the agenda and have had no influence over the agenda, the speakers or the content of the meeting.

Please confirm:

This is an in person event. By booking, you agree that a no-show fee may be charged if you fail to attend and do not cancel at least 12 hours before the event.